Lesion-related white matter tract disconnection is strongly associated with clinical impairment in patients diagnosed with relapsing-remitting multiple sclerosis, according to findings from a retrospective cohort study. While structural disconnection across cerebral pathways demonstrated robust statistical relationships with physical and cognitive disability metrics, baseline disconnection patterns showed only exploratory associations with subsequent disease progression. Specifically, structural disconnection failed to reliably distinguish between patients who eventually transitioned into secondary progressive multiple sclerosis and individuals who maintained a relapsing-remitting disease course once statistical corrections were applied. The investigation systematically assessed structural connectivity across sixty-four distinct white matter tracts to clarify whether focal lesion damage translating into pathway disconnection could explain ongoing neurological impairment or predict clinical conversion over time.
The retrospective cohort comprised ninety-five adult participants diagnosed with relapsing-remitting multiple sclerosis at study entry. Within this clinical cohort, thirty-one patients subsequently experienced disease progression and converted to secondary progressive multiple sclerosis during clinical observation, whereas sixty-four individuals remained classified as non-converters. In addition to comprehensive index clinical evaluations, longitudinal magnetic resonance neuroimaging data were collected for a substantial subset of the study group, with follow-up brain scans available for seventy-four patients. By comparing clinical trajectories and neuroimaging findings between the converter and non-converter cohorts, the researchers sought to identify structural biomarkers capable of differentiating patients at risk of secondary progressive conversion from those maintaining a relapsing course.
Neuroimaging protocols utilized baseline or index scans alongside available follow-up magnetic resonance acquisitions, focusing on high-resolution three-dimensional T1-weighted sequences and fluid-attenuated inversion recovery images. These anatomical imaging series were processed through the automated online volBrain DeepLesionBrain analytical pipeline. This computational framework enabled the researchers to model focal demyelinating lesions and quantify structural disconnection probabilities across sixty-four pre-defined white matter tracts throughout the cerebral hemispheres.
Clinical assessments captured a broad spectrum of neurological disability, ambulatory capacity, upper-limb manual dexterity, information processing speed, and disease activity. Standardized clinical metrics included the Expanded Disability Status Scale, the Timed Twenty-Five Foot Walk Test, the Nine-Hole Peg Test, and the Symbol Digit Modalities Test, alongside functional system scores and historical relapse burden. Comparison of baseline clinical characteristics revealed pronounced differences between the patient subgroups. Individuals who subsequently converted to secondary progressive multiple sclerosis exhibited significantly higher overall disability on the Expanded Disability Status Scale, experienced an increased relapse burden, required more time to complete the Timed Twenty-Five Foot Walk Test, and demonstrated poorer performance on the Nine-Hole Peg Test compared to non-converters.
Statistical evaluations comparing baseline and index tract disconnection between future converters and non-converters employed Mann-Whitney U tests, multivariable logistic regression models, and receiver operating characteristic curve analyses. While initial unadjusted comparisons indicated several nominal group differences in baseline white matter tract disconnection, none of these differences survived correction for multiple hypothesis testing using the false discovery rate approach. To rigorously test the stability of these findings, the investigators conducted extensive sensitivity analyses, including reduced clinical models, lesion-adjusted models, full adjusted multivariable models, and scanner-adjusted models. Across all tested sensitivity configurations, no white matter tract exhibited a nominally significant or false discovery rate-corrected association with conversion status.
The investigators also conducted additional sensitivity analyses utilizing a binary classification framework that defined each tract simply as either disconnected or intact, rather than evaluating continuous disconnection probabilities. Similar to the continuous models, the binary disconnection analyses identified no individual white matter tract that retained a statistically significant relationship with secondary progressive conversion following false discovery rate correction. These concordant negative outcomes across varied modeling paradigms indicate that tract disconnection measurements derived from baseline magnetic resonance scans cannot reliably predict progression to secondary progressive multiple sclerosis.
In striking contrast to the negative findings regarding secondary progressive conversion, lesion-related white matter tract disconnection correlated extensively and robustly with concurrent clinical disability in relapsing-remitting multiple sclerosis. Correlation analyses using Spearman rank correlation coefficients evaluated associations between tract-level disconnection probabilities, clinical disability scores, and lesion-derived magnetic resonance parameters. Following rigorous false discovery rate correction, ninety distinct tract-disconnection correlations remained statistically significant.
Longitudinal neuroimaging assessments evaluated whether the rate or pattern of progressive white matter tract disconnection over time differed between individuals who converted and those who did not. After applying false discovery rate adjustments, longitudinal changes in tract disconnection did not significantly diverge between converters and non-converters. The authors concluded that while lesion-induced white matter tract disconnection provides a powerful structural correlate of existing clinical disability in relapsing-remitting multiple sclerosis, its relationship with secondary progressive disease conversion remains purely exploratory. Consequently, baseline white matter tract disconnection profiles cannot currently serve as definitive prognostic indicators of progression, underscoring the necessity of distinguishing concurrent physical impairment from prospective transition toward secondary progressive multiple sclerosis.
Subject of Research: White matter tract disconnection and clinical progression in relapsing-remitting multiple sclerosis
Article Title: Lesion-related white matter disconnection in relapsing-remitting multiple sclerosis: clinical associations and exploratory analysis of conversion to secondary progressive multiple sclerosis
Article References: Hannoun, S., Najjar, N. M., Siddik, M. A., Halawi, L., Al-Dahouk, C., Semaan, M. G., El-Ayoubi, N. K., & Khoury, S. J. (2026). Lesion-related white matter disconnection in relapsing-remitting multiple sclerosis: clinical associations and exploratory analysis of conversion to secondary progressive multiple sclerosis. BMC Neurology. https://doi.org/10.1186/s12883-026-05556-3
Image Credits: AI Generated
DOI: 10.1186/s12883-026-05556-3
Keywords: relapsing-remitting multiple sclerosis, secondary progressive multiple sclerosis, white matter tract disconnection, Expanded Disability Status Scale, Symbol Digit Modalities Test, Timed 25-Foot Walk Test, 9-Hole Peg Test, DeepLesionBrain pipeline, volBrain, FLAIR imaging, T1-weighted MRI, relapse burden, false discovery rate correction, retrospective cohort study, structural connectivity, neuroimaging biomarkers
News Source: Ophelia Keating. (November 11, 2026). White Matter Disconnection Tracks Disability but Not Progression in Multiple Sclerosis. Scienmag.



